Results 11 to 20 of about 272 (122)

Lentes intraoculares bifocales [PDF]

, 2020
Context: Les lents intraoculars són utilitzades per poder compensar poders diòptrics ja siguin refractius, en el cas de les ICL, o el poder diòptric del cristal·lí quan aquest s’extreu mitjançant una intervenció, com seria el cas de les cataractes ...
Baldich Arroyo, Ariadna
core   +2 more sources

Lentes intraoculares en 2022 [PDF]

, 2023
El cristal·lí és una lent natural de potència variable situada en el glòbul ocular. Presenta dues característiques importants: la seva transparència i elasticitat.
Espino Morante, Paula
core   +2 more sources

Lentes intraoculares compensadoras de la presbicia [PDF]

, 2021
La pérdua de transparencia del cristal·lí, la lent natural que ens permet enfocar a totes les distàncies, es comú en la població major de 60 anys aproximadament. Aquesta opacificació rep el nom de cataracta.
García Valdéz, María del Mar
core   +2 more sources

Comparativa de lents intraoculars isofocals i monofocals [PDF]

Objectiu: Comparar una lent isofocal, Eyhance, amb un grup de monofocals per determinar si permet una millor visió a distàncies més curtes, sense sacrificar la visió llunyana i la sensibilitat al contrast.
Genescà Pujols, Sílvia
core   +2 more sources

Lentes intraoculares acomodativas

, 2022
La presbicia, signo inequívoco del envejecimiento, sigue siendo «una enfermedad sin tratamiento universal, que sin duda tiene muchos tratamientos». Presenta múltiples intentos de abordaje realizados por la oftalmología hasta la fecha. En una disciplina donde los resultados son cada vez más precisos, los oftalmólogos, y los cirujanos refractivos en ...
Peris Martínez, Cristina, Alfonso Muñoz, Enrique Antonio, Roig Revert, María José, Fernández-López, Ester, Hernández López, Mikhail, Montolío Marzo, Santiago, Piá Ludeña, José Vicente, Ortega Evangelio, Leticia   +7 more
openaire   +1 more source

Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review

British Journal of Pharmacology, Volume 183, Issue 9, Page 1779-1813, May 2026.
Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos, Stavros Topouzis, Steve P. H. Alexander, Miriam M. Cortese‐Krott, Zsuzsanna Helyes, Kirill Martemyanov, Claudio Mauro, Nithyanandan Nagercoil, Reynold A. Panettieri Jr, Hemal H. Patel, Rainer Schulz, Barbara Stefanska, Gary J. Stephens, Nathalie Vergnolle, Xin Wang, Stephen Ward, Péter Ferdinandy   +16 more
wiley   +1 more source

Noninvasive 11.7‐T Magnetic Resonance Spectroscopy and Imaging Reveals Retinal Metabolic Alterations Induced by Blue Light Exposure

NMR in Biomedicine, Volume 39, Issue 3, March 2026.
Retinal metabolic changes were analyzed using proton magnetic resonance spectroscopy (1H‐MRS), marking an initial application of this non‐invasive method on living eyes. Key metabolites were identified within the retinal region of adult rats. The observed changes following intense blue light exposure were predominantly attributable to the retina, as it
Lacramioara Samoila, Alexandru Farcasanu, Simion Simon, Ede Bodoki, Ovidiu Samoila, Oliviu Vostinaru, Elena Dinte, Andreea Elena Bodoki, Dan Iudean, Calin Muresan, Simona Clichici   +10 more
wiley   +1 more source

Personalized Models of Biological Barriers and Their Diseases: Recent Progress with Organs‐On‐Chips

Advanced Biology, Volume 10, Issue 2, February 2026.
Buck and Bugter et al. explore the architectural diversity and physiological functions of human barrier systems and reveal how organ‐on‐chip platforms, particularly those integrating patient‐derived cells, are advancing barrier disease modeling. They highlight how emerging biological and technological advances can be used to bridge the gap between ...
Franziska Buck, Jeroen Bugter, Gizem Yorukoglu, Mina Kazemzadeh Dastjerd, Thomas E. Winkler   +4 more
wiley   +1 more source

Nanobiotechnology‐Based Approaches for Uveal Melanoma Treatment

SmartMat, Volume 7, Issue 1, February 2026.
Emerging platforms for uveal melanoma combine precision drug delivery, ROS‐amplifying modalities, and nucleic acid transport to overcome ocular barriers and immunosuppressive niches. Targeted nanoparticles, virus‐like constructs, and injectable depots enable localized activation, controlled release, and gene‐level reprogramming.
Nadezhda A. Pechnikova, Ioannis Iliadis, Malamati Poimenidou, Chrysi Patsidou, Maria Zafeiriou‐Chatziefraimidou, Diamantis D. Almaliotis, Ioannis T. Tsinopoulos, Ivan V. Zelepukin, Alexey V. Yaremenko   +8 more
wiley   +1 more source

Cardiovascular response to altered gravity in healthy adults: Insight from graded tilt testing

Physiological Reports, Volume 14, Issue 4, February 2026.
Abstract Microgravity exposure during spaceflight induces a thoracocephalic fluid shift that affects the cardiovascular system both during flight and after return to Earth. As the proportion of female astronauts increases, it is essential to understand how altered gravity impacts cardiovascular function across sexes.
Adrien Robin, Richard S. Whittle, Ana Diaz‐Artiles   +2 more
wiley   +1 more source